Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.
Journal: Blood advances
Published: April 15, 2025
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.
Journal: Blood advances
Published: April 15, 2025
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.
Journal: Blood advances
Published: April 15, 2025
Impact of Graft-Versus-Host Disease on Relapse and Nonrelapse Mortality Following Posttransplant Cyclophosphamide-Based Transplantation.
Journal: Transplantation and cellular therapy
Published: April 08, 2024
Intrathecal chemotherapy as treatment for chimeric antigen receptor T cell (CAR T) therapy associated neurotoxicity.
Journal: Bone marrow transplantation
Published: March 19, 2024
Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival following Haploidentical Transplant.
Journal: Transplantation and cellular therapy
Published: February 03, 2024
Immunosuppression-Free Status at 1 Year after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: January 30, 2024
Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant.
Journal: Blood advances
Published: April 17, 2023
Lineage-Specific Relapse Prediction After Haploidentical Transplantation With Post-Transplant Cyclophosphamide Based on Recipient HLA-B-Leader Genotype and HLA-C-Group KIR Ligand.
Journal: Transplantation and cellular therapy
Published: May 06, 2022
High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple Myeloma.
Journal: Transplantation and cellular therapy
Published: March 23, 2022
Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD).
Journal: Bone marrow transplantation
Published: September 27, 2021
Last Updated: 09/26/2026